Kedrion Biopharma and Kamada Receive FDA Approval of KEDRAB™ for Post-Exposure Prophylaxis Against Rabies Infection
KEDRAB™ [rabies immune globulin (Human)], a plasma-derived human rabies immune globulin (HRIG), represents new entry into $100 million-plus U.S. rabies prevention market where only two other products exist. Rabies, a serious public health concern, is one …